NEOS Investment Management LLC Acquires 8,709 Shares of MetLife, Inc. (NYSE:MET)

NEOS Investment Management LLC raised its stake in shares of MetLife, Inc. (NYSE:MET - Free Report) by 31.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,601 shares of the financial services provider's stock after buying an additional 8,709 shares during the period. NEOS Investment Management LLC's holdings in MetLife were worth $2,997,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Kingsview Wealth Management LLC increased its position in MetLife by 14.8% in the 3rd quarter. Kingsview Wealth Management LLC now owns 3,899 shares of the financial services provider's stock worth $322,000 after buying an additional 502 shares during the period. Larson Financial Group LLC increased its position in shares of MetLife by 59.5% during the third quarter. Larson Financial Group LLC now owns 906 shares of the financial services provider's stock valued at $75,000 after purchasing an additional 338 shares during the period. D.A. Davidson & CO. boosted its holdings in MetLife by 3.1% during the third quarter. D.A. Davidson & CO. now owns 22,294 shares of the financial services provider's stock valued at $1,839,000 after purchasing an additional 671 shares in the last quarter. FMR LLC raised its holdings in shares of MetLife by 5.4% in the 3rd quarter. FMR LLC now owns 2,209,119 shares of the financial services provider's stock worth $182,208,000 after buying an additional 112,491 shares in the last quarter. Finally, Glenmede Trust Co. NA lifted its position in shares of MetLife by 3.0% during the 3rd quarter. Glenmede Trust Co. NA now owns 27,626 shares of the financial services provider's stock worth $2,279,000 after buying an additional 809 shares during the period. Institutional investors own 94.99% of the company's stock.

Remove Ads

MetLife Stock Performance

NYSE:MET traded up $0.76 on Wednesday, reaching $81.92. 1,164,660 shares of the company's stock were exchanged, compared to its average volume of 3,273,400. The firm has a market cap of $55.80 billion, a price-to-earnings ratio of 13.72, a P/E/G ratio of 0.65 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a fifty day simple moving average of $83.04 and a 200-day simple moving average of $83.01. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05.

MetLife (NYSE:MET - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, sell-side analysts predict that MetLife, Inc. will post 9.65 earnings per share for the current year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th were issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date was Tuesday, February 4th. MetLife's payout ratio is 36.52%.

Wall Street Analyst Weigh In

MET has been the subject of a number of research analyst reports. StockNews.com downgraded shares of MetLife from a "buy" rating to a "hold" rating in a research note on Thursday, January 9th. Barclays dropped their target price on MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a research report on Friday, February 7th. JPMorgan Chase & Co. lowered their price objective on MetLife from $88.00 to $86.00 and set an "overweight" rating for the company in a research report on Wednesday. Cowen restated a "buy" rating on shares of MetLife in a research report on Friday, March 7th. Finally, Keefe, Bruyette & Woods lowered their price target on shares of MetLife from $100.00 to $98.00 and set an "outperform" rating for the company in a research report on Wednesday, February 12th. Two investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $94.85.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.